Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Clinical trial NCT00193271 · COMPLETED

Trial details

NCT number: NCT00193271
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2004-08-01
Primary completion: 2007-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.